Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients : a multicenter study in Korea
© 2014..
We performed a case-control study to identify risk factors of carbapenem-resistant Gram-negative bacteria (CRGNB) as an increasing cause of hospital-acquired pneumonia (HAP). The study included critically ill adult patients with HAP whose microbial etiology was identified at eight tertiary centers in Korea between June 2008 and December 2009. Eighty two patients with 86 isolates of CRGNB (62 Acinetobacter baumannii, 14 Pseudomonas aeruginosa, and 10 Stenotrophomonas maltophilia) were included in the case group, and 122 patients with carbapenem-susceptible Gram-negative bacteria were included in the control group. Diabetes mellitus (adjusted odds ratio [aOR] 2.82, 95% confidence interval [95% CI] 1.25-6.38), radiologic score ≥5 (aOR 4.56, 95% CI 2.36-8.81), prior fluoroquinolone (aOR 2.39. 95% CI = 1.07-5.35), or carbapenem usage (aOR 2.82, 95% CI 1.75-17.83) were found to be independent risk factors. Fluoroquinolone and carbapenem should be cautiously used to avoid HAP caused by CRGNB.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
---|---|
Enthalten in: |
Diagnostic microbiology and infectious disease - 78(2014), 4 vom: 15. Apr., Seite 457-61 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kim, Tark [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-Bacterial Agents |
---|
Anmerkungen: |
Date Completed 03.11.2014 Date Revised 17.03.2014 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.diagmicrobio.2013.08.011 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM234831391 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM234831391 | ||
003 | DE-627 | ||
005 | 20231224102115.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.diagmicrobio.2013.08.011 |2 doi | |
028 | 5 | 2 | |a pubmed24n0782.xml |
035 | |a (DE-627)NLM234831391 | ||
035 | |a (NLM)24462178 | ||
035 | |a (PII)S0732-8893(13)00457-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kim, Tark |e verfasserin |4 aut | |
245 | 1 | 0 | |a Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients |b a multicenter study in Korea |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.11.2014 | ||
500 | |a Date Revised 17.03.2014 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2014. | ||
520 | |a We performed a case-control study to identify risk factors of carbapenem-resistant Gram-negative bacteria (CRGNB) as an increasing cause of hospital-acquired pneumonia (HAP). The study included critically ill adult patients with HAP whose microbial etiology was identified at eight tertiary centers in Korea between June 2008 and December 2009. Eighty two patients with 86 isolates of CRGNB (62 Acinetobacter baumannii, 14 Pseudomonas aeruginosa, and 10 Stenotrophomonas maltophilia) were included in the case group, and 122 patients with carbapenem-susceptible Gram-negative bacteria were included in the control group. Diabetes mellitus (adjusted odds ratio [aOR] 2.82, 95% confidence interval [95% CI] 1.25-6.38), radiologic score ≥5 (aOR 4.56, 95% CI 2.36-8.81), prior fluoroquinolone (aOR 2.39. 95% CI = 1.07-5.35), or carbapenem usage (aOR 2.82, 95% CI 1.75-17.83) were found to be independent risk factors. Fluoroquinolone and carbapenem should be cautiously used to avoid HAP caused by CRGNB | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Carbapenem-resistant Gram-negative bacteria | |
650 | 4 | |a Hospital-acquired pneumonia | |
650 | 4 | |a Risk factor | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Carbapenems |2 NLM | |
700 | 1 | |a Chong, Yong Pil |e verfasserin |4 aut | |
700 | 1 | |a Park, Seong Yeon |e verfasserin |4 aut | |
700 | 1 | |a Jeon, Min-Hyok |e verfasserin |4 aut | |
700 | 1 | |a Choo, Eun Joo |e verfasserin |4 aut | |
700 | 1 | |a Chung, Jin-Won |e verfasserin |4 aut | |
700 | 1 | |a Lee, Hyun Kyung |e verfasserin |4 aut | |
700 | 1 | |a Moon, Chisook |e verfasserin |4 aut | |
700 | 1 | |a Kim, Dong-Min |e verfasserin |4 aut | |
700 | 1 | |a Peck, Kyong Ran |e verfasserin |4 aut | |
700 | 1 | |a Kim, Yang Soo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diagnostic microbiology and infectious disease |d 1986 |g 78(2014), 4 vom: 15. Apr., Seite 457-61 |w (DE-627)NLM01262845X |x 1879-0070 |7 nnns |
773 | 1 | 8 | |g volume:78 |g year:2014 |g number:4 |g day:15 |g month:04 |g pages:457-61 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.diagmicrobio.2013.08.011 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 78 |j 2014 |e 4 |b 15 |c 04 |h 457-61 |